Alpha Teknova, Inc. Common Stock (TKNO) Stock Price

TKNOStock

$7.08+34.60%52W

Market Cap$380.11M

P/E—

PEG Ratio—

Div yield—

Beta0.95

TKNO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)123.76%

Price vs S&P 500 (4W)-13.78%

VGM Score56.27

Book Value / Share (Quarterly)$1.17

P/TBV (Annual)3.58x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-0.73%

Cash Flow / Share (Quarterly)$-0.14

Price vs S&P 500 (YTD)74.39%

Gross Margin (TTM)34.60%

Net Profit Margin (TTM)-38.37%

EPS (TTM)$-0.31

10-Day Avg Trading Volume0.30M

EPS Excl Extra (TTM)$-0.31

Revenue Growth (5Y)5.30%

EPS (Annual)$-0.32

ROI (Annual)-21.07%

Gross Margin (Annual)33.17%

Net Profit Margin (5Y Avg)-70.98%

Cash / Share (Quarterly)$0.32

Revenue Growth QoQ (YoY)18.45%

ROA (Last FY)-16.66%

Revenue Growth TTM (YoY)12.27%

EBITD / Share (TTM)$-0.27

ROE (5Y Avg)-30.55%

Operating Margin (TTM)-36.19%

Cash Flow / Share (Annual)$-0.18

P/B Ratio6.07x

P/B Ratio (Quarterly)4.86x

Net Income / Employee (Annual)$-109,200

EV / Revenue (TTM)8.86x

Net Interest Coverage (TTM)-23.23x

ROA (TTM)-16.53%

EPS Incl Extra (Annual)$-0.32

Current Ratio (Annual)4.58x

Quick Ratio (Quarterly)3.32x

3-Month Avg Trading Volume0.24M

52-Week Price Return34.60%

Revenue / Employee (TTM)$276,600

Tangible BV / Share (Quarterly)$0.95

P/S Ratio (Annual)9.38x

Asset Turnover (Annual)0.39x

52-Week High$9.48

Operating Margin (5Y Avg)-72.56%

EPS Excl Extra (Annual)$-0.32

CapEx CAGR (5Y)-26.82%

26-Week Price Return133.66%

Quick Ratio (Annual)3.44x

13-Week Price Return30.63%

Total Debt / Equity (Annual)0.19x

Current Ratio (Quarterly)4.49x

Enterprise Value$387.33M

Revenue / Share Growth (5Y)-8.08%

Asset Turnover (TTM)0.43x

Revenue / Employee (Annual)$256,500

Inventory Turnover (Annual)3.91x

Pretax Margin (Annual)-42.45%

Cash / Share (Annual)$0.40

3-Month Return Std Dev61.21%

Gross Margin (5Y Avg)34.07%

Net Income / Employee (TTM)$-106,100

ROE (Last FY)-25.09%

Net Interest Coverage (Annual)-18.12x

EPS Basic Excl Extra (Annual)$-0.32

Receivables Turnover (TTM)8.29x

Total Debt / Equity (Quarterly)0.21x

EPS Incl Extra (TTM)$-0.31

Receivables Turnover (Annual)9.07x

ROI (TTM)-20.86%

P/S Ratio (TTM)8.70x

Pretax Margin (5Y Avg)-73.62%

Revenue / Share (Annual)$0.76

Tangible BV / Share (Annual)$1.06

Price vs S&P 500 (52W)19.07%

Year-to-Date Return86.32%

5-Day Price Return-18.62%

EPS Normalized (Annual)$-0.32

ROA (5Y Avg)-20.97%

Net Profit Margin (Annual)-42.59%

Month-to-Date Return-20.45%

Cash Flow / Share (TTM)$-1.21

EBITD / Share (Annual)$-0.30

Operating Margin (Annual)-41.90%

LT Debt / Equity (Annual)0.19x

ROI (5Y Avg)-25.97%

LT Debt / Equity (Quarterly)0.21x

EPS Basic Excl Extra (TTM)$-0.31

P/TBV (Quarterly)5.94x

P/B Ratio (Annual)2.96x

Inventory Turnover (TTM)3.94x

Pretax Margin (TTM)-38.16%

Book Value / Share (Annual)$1.28

Price vs S&P 500 (13W)27.94%

Beta0.95x

Revenue / Share (TTM)$0.81

ROE (TTM)-24.94%

52-Week Low$1.91

vGradeD

gGradeC

mGradeB

vgmGradeC

TKNO Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.07	-$0.05	+32.14%(+$0.02)
Q1 2026	May 6, 2026	-$0.09	-$0.08	+13.04%(+$0.01)
Q4 2025	Feb 26, 2026	-$0.09	-$0.09	+2.17%(+$0.00)
Q3 2025	Nov 6, 2025	-$0.09	-$0.08	+14.89%(+$0.01)
Q2 2025	Aug 7, 2025	-$0.10	-$0.07	+30.00%(+$0.03)

TKNO Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.08

4.23

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
TKNOAlpha Teknova, Inc. Common Stock	D	C	B	8.7x	12.3%	34.6%	—	$7.08
IDXXIdexx Laboratories Inc	D	B	B	9.7x	12.8%	62.5%	14.3%	$560.36
LNTHLantheus Holdings, Inc	C	B	B	4.2x	2.4%	61.0%	40.7%	$99.70
NEOGNeogen Corp	C	C	A	2.9x	-0.3%	47.4%	—	$11.81
CLDXCelldex Therapeutics, Inc	F	F	C	13683.0x	-97.3%	17.6%	—	$27.53
NTLAIntellia Therapeutics, Inc	D	D	C	26.9x	12.6%	—	—	$11.42
QDELQuidelOrtho Corporation Common Stock	C	C	C	0.3x	-2.5%	44.6%	—	$12.91
ACHVAchieve Life Sciences, Inc.	F	F	B	36.8x	-89.3%	—	—	$6.38
MYGNMyriad Genetics Inc	C	C	D	0.5x	-3.2%	68.8%	—	$3.98
NNNNAnbio Biotechnology Class A Ordinary Shares	F	C	F	34.0x	-5.7%	89.0%	—	$3.13
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	59.0x	-60.8%	48.3%	—	$3.01
ICCCImmucell Corp	C	C	A	3.2x	8.5%	40.3%	—	$10.75
BMRABIOMERICA INC	B	D	B	1.9x	-16.2%	8.1%	—	$1.85
TRIBTrinity Biotech plc	B	D	C	0.1x	-16.6%	32.9%	—	$8.03
VNRXVolitionRx Limited	B	B	F	2.0x	86.3%	—	—	$0.18
CDIOCardio Diagnostics Holdings Inc. Common stock	—	D	C	345.9x	-25.9%	—	—	$1.69
QCLSQ/C Technologies, Inc. Common Stock	B	—	F	5.3x	—	24.7%	—	$0.54
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	F	156.9x	96.4%	62.0%	—	$1.45
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	F	—	—	—	—	$0.01

About Alpha Teknova, Inc. Common Stock

Alpha Teknova Inc manufactures critical reagents used in the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company offers two primary product lines—Lab Essentials and Clinical Solutions—comprised of pre-poured culture media plates, liquid microbial media, and molecular biology reagents for sample preparation and purification. Primary revenue is generated from the United States market.